On June 26, Gelunhui reported that an investor asked Shanxi C&Y Pharmaceutical Group on the investor interaction platform, "What products have your company obtained foreign market approval, such as in the United States or Europe?" The company replied that currently, the company has no products that have obtained foreign market approval in the United States or Europe, and the company's products are mainly sold domestically.
仟源医药(300254.SZ)：目前没有产品取得美国或欧洲等国外上市许可
Currently shanxi c&y pharmaceutical group (300254.SZ) has not obtained any product foreign listing licenses in countries such as the USA or Europe.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.